logo
14:29 Apr 29

Cohance Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
472.60
-20.70 (-4.20%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Cohance Lifesciences Ltd. Financials

Cohance Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
472.60
-20.70 (-4.20%)
14:29 Apr 29
Quality
image/svg+xml

37/100
Medium Financial Strength

Valuation
image/svg+xml

26/100
Expensive Valuation

Technical

45/100
Technically Neutral

Strength

3

Weakness

7

Opportunity

0

Threats

0

15.78 %

ROE %

8.83 %

ROA %

5.27

EPS

66.64

BVPS

22.36 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1320.22 1340.33 1051.35 1197.58 2051.45
Operating Expenses +
740.79 773.79 645.54 822.38 1649.58
Raw Material
459.46 430.08 265.88 222.66 636.67
Increase Decrease in Cost
-60.35 -20.94 49.16 82.63 -54.49
Other Manufacturing Expense
173.19 176.29 133.48 0 0
Employee Cost
100.48 110.51 135.92 249.56 467.8
Miscellaneous Expenses
68.01 77.85 61.1 267.53 599.6
Operating Profit
579.43 566.54 405.81 375.2 401.87
Other Income
92.38 46.36 61.91 58.56 46.5
Depreciation
39.1 47.73 54.6 77.49 162.88
Interest
6.23 5.44 7.45 12.35 33.8
Profit before tax and exceptio..
626.48 559.73 405.67 343.92 251.69
Exceptional Items
0 0 0 0 -12.96
PBT
626.48 559.73 405.67 343.92 264.65
Provision for Taxation
213.78 148.44 105.39 79.15 58.19
Net Profit
412.69 411.29 300.28 264.77 180.54
NET Profit after MI
453.8 411.29 300.28 267.87 201.69
EPS
17.83 16.16 11.8 10.52 5.83
Operating Profit Margin (%)
43.89 42.27 38.6 31.33 19.59
Net Profit Margin (%)
34.37 30.69 28.56 22.37 9.83

Cohance Lifesciences Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: